Beam Therapeutics Inc.

Direct answer

Beam Therapeutics Inc. is publicly traded on NASDAQ under the ticker BEAM.

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta...

Can you invest in Beam Therapeutics Inc.?

Yes. Beam Therapeutics Inc. is publicly traded on NASDAQ under the ticker BEAM.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Beam Therapeutics Inc.

Detailed equity research is provided by MarketSnap.